Adiponectin-related abnormalities in lipid metabolism can lead to insulin resistance, which predisposes toward glucose metabolism disorders (58, 59), while conversely, glucose metabolism disorders result in greater fatty acid oxidation and glycosylation, which in turn affect lipid metabolism (60). This evidence concerns the gene ADIPOQ and glucose metabolism disease.